Animal Protection Accountability Improvement Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
67pct
24d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (10)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2008 · fourth_quarter · Health Issues
-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Health Issues
-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Animals
Animal Fighting, HR l37, S26l; Horse Slaughter, HR 503, S.3ll; Primates as Pets,HR 2964, S l498; Downed Animals, HR 66l, S.394; Bear Protection Act, HR 5534; Chimpanzee Research Legislation, HR 3295, S. 1916; Dog fighting, HR 32l9, HR 3327, S.l880; Polar Bear Imports, HR 2327 and S.1406; Wild Horses, HR 249; Fur Labeling, S 3610; Puppy Mills/Import Ban; Animal Welfare Act Accountability, HR 2193; Service Horse Adoption; Human and Pet Food Safety, HR 2108 and S 1274; Trophy Hunting; Internet Hunting, HR 2711, S 2422; Animal Cruelty Reporting, S 2439, HR 6597; Class B Dealer, HR 1280, S. 714
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Animals
HR 1280, S 714, Pet Safety and Protection Act--Issue: To retain Class B animal dealers as a possible source for laboratory animals HR 2193, Animal Protection Accountability Act--Issue: To retain Class B animal dealers as a possible source for laboratory animals
Client expense: $160,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
H.R. 6381, Medical Device Safety Act H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008 H.R. 2193, Animal Protection Accountability Improvement Act Research on Bariatric Surgery
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · fourth_quarter · Health Issues
-H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S.2274, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan", and for other purposes, regarding all provisions. -S.3409 "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration", and for other purposes; regarding all provisions. -S.1378 "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan", and for other purposes; regarding all provisions. -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; -S.2424, "A bill to ensure that all Americans have basic health literacy skills to function effectively as patients and health care consumers", regarding all provisions.
2008 · fourth_quarter · Animals
Animal Welfare Act Regulations & Policies H.R. 1280 and S. 714, Pet Safety & Protection Act of 2007 H.R. 2193, Animal Protection Accountability Improvement Act H.R. 5852 Great Ape Protection Act
Client expense: $20,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
HR 2193 Animal Protection Accountability Improvement Act; HR 6381 Medical Device Safety Act; HR 6151 Responsibility in Drug and Device Advertising Act of 2008; General issues related to healthcare and healthcare reimbursement.
Client expense: $480,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Animals
Animal Welfare Act Regulations & Policies H.R. 1280 and S. 714, Pet Safety & Protection Act of 2007 H.R. 2193, Animal Protection Accountability Improvement Act H.R. 2419, the Farm, Nutrition, and Bioenergy Act of 2007, title XI, Subtitle D, Sec. 11316 and 11317 HR 2419 (Senate version), Food and Energy Security Act of 2007, Title XI, Sec. 11079 HR 5852 Great Ape Protection Act
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Animals
Animal Fighting, HR l37, S26l; Horse Slaughter, HR 503, S.3ll; Primates as Pets,HR 2964, S l498; Downed Animals, HR 66l, S.394; Bear Protection Act, HR 5534; Chimpanzee Research Legislation; Dog fighting, HR 32l9, HR 3327, S.l880; Polar Bear Imports, HR 2327 and S.1406; Wild Horses, HR 249; Fur Labeling, HR 89l; Puppy Mills/Import Ban; Animal Welfare Act Accountability, HR 2193; Service Horse Adoption; Human and Pet Food Safety, HR 2108 and S 1274; Trophy Hunting; Internet Hunting, HR 2711, S 2422; Animal Cruelty Reporting, S 2439, HR 6597;
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Animals
HR 1280, S 714, Pet Safety and Protection Act--To retain Class B animal dealers as a possible source for laboratory animals HR 2193 Animal Protection Accountability Act--To retain Class B animal dealers as a possible source for laboratory animals
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2008 · third_quarter · Health Issues
HR 2193 Animal Protection Accountability Improvement Act; HR 6381 Medical Device Safety Act; HR 6151 Responsibility in Drug and Device Advertising Act of 2008; General issues related to the healthcare industry; General issues regarding domestic and international reimbursement and procurement for medical products.
Client expense: $450,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
2008 · third_quarter · Health Issues
-H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; -H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions;
2008 · third_quarter · Health Issues
H.R. 6381, Medical Device Safety Act H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008 H.R. 2193, Animal Protection Accountability Improvement Act Research on Bariatric Surgery
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · third_quarter · Animals
Animal Welfare Act Regulations & Policies H.R. 1280 and S. 714, Pet Safety & Protection Act of 2007 H.R. 2193, Animal Protection Accountability Improvement Act H.R. 5852 Great Ape Protection Act
Client expense: $20,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Animals
Animal Welfare Act Regulations & Policies H.R. 1280 and S. 714, Pet Safety & Protection Act of 2007 H.R. 2193, Animal Protection Accountability Improvement Act H.R. 2419, the Farm, Nutrition, and Bioenergy Act of 2007, title XI, Subtitle D, Sec. 11316 and 11317 HR 2419 (Senate version), Food and Energy Security Act of 2007, Title XI, Sec. 11079 HR 5852 Great Ape Protection Act
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Animals
HR 1280, S 714 Pet Safety and Protection Act - To retain Class B animal dealers as a possible source for laboratory animals HR 2193 Animal Protection Accountability Act - To retain Class B animal dealers as a possible source for laboratory animals
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Animals
Animal Welfare Act Regulations & Policies H.R. 1280 and S. 714, Pet Safety & Protection Act of 2007 H.R. 2193, Animal Protection Accountability Improvement Act H.R. 2419, the Farm, Nutrition, and Bioenergy Act of 2007, Title XI, Subtitle D, Sec. 11316 and Sec. 11317 H.R. 2419 (Senate version), Food and Energy Security Act of 2007, Title XI, Sec. 11079 H.R. 5852 Great Ape Protection Act
Client expense: $30,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; H.R. 5839, "To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs", regarding all provisions; S. 334, "A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away", regarding all provisions; H.R. 6381, "To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions; S. 438, "A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs", regarding all provisions.
2008 · second_quarter · Animals
Animal Welfare Act Regulations & Policies H.R. 1280 and S. 714, Pet Safety & Protection Act of 2007 H.R. 2193, Animal Protection Accountability Improvement Act H.R. 2419, the Farm, Nutrition, and Bioenergy Act of 2007, title XI, Subtitle D, Sec. 11316 and 11317 H.R. 2419 (Senate version), Food and Energy Security Act of 2007, Title XI, Sec. 11079 H.R. 5852 Great Ape Protection Act
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Animals
HR 1280, S 714 Pet Safety and Protection Act - To retain Class B animal dealers as a possible source for laboratory animals HR 2193 Animal Protection Accountability Act - To retain Class B animal dealers as a possible source for laboratory animals
Client expense: $170,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2008 · first_quarter · Health Issues
H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products.
2008 · first_quarter · Animals
Monitoring all issues related to animal welfare; Lobbied the following bills in entirety: H.R. 2964/S.1498, Captive Primate Safety Act H.R. 5534/H.R. 3029, the Bear Protection Act of 2008 H.R. 5852, The Great Ape Protection Act H.R. 661/S.394, Downed Animal and Food Safety Protection Act H.R. 891, Dog and Cat Fur Prohibition Enforcement Act H.RES.427/S.RES.118, Urging the Government of Canada to end the commercial seal hunt. H.R.2711/S.2422, Computer-Assisted Remote Hunting Act H.R.3219/H.R.3327/S. 1880, To amend the Animal Welfare Act to prohibit dog fighting ventures H.R.2193, Animal Protection Accountability Improvement Act Monitored issues relating to animal welfare (specifically Dog Fighting, Class B Dealers, and Puppy Imports) in the following bills: H.R.2419/H.R.5813/S.AMDT.3776/S.AMDT.3619, Farm Bill Extension Act of 2007 FY09 Appropriations Bill (not yet introduced); lobbied the following issues: Food Safety and Inspection Service / Humane Methods of Slaughter Act (HMSA) Enforcement APHIS / Animal Welfare Act (AWA) Enforcement APHIS / Investigative and Enforcement Services Office of Inspector General / Animal Fighting Enforcement Cooperative State Research, Education, and Extension Service / Veterinary Student Loan Forgiveness APHIS / Emergency Management Systems / Disaster Planning for Animals
Client expense: Not reported · Firm income: $20,000
2008 · first_quarter · Animals
Animal Welfare Act Regulations & Policies H.R. 1280 and S. 714, Pet Safety & Protection Act of 2007 H.R. 2193, Animal Protection Accountability Improvement Act H.R. 2419, the Farm, Nutrition and Bioenergy Act of 2007, Title XI, Subtitle D. Sec. 11316 and Sec. 11317 H.R. 2419 (Senate version), Food and Energy Security Act of 2007, Title XI, Sec. 11079
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Animals
Animal Welfare Act Regulations & Policies H.R. 1280 and S. 714, Pet Safety & Protection Act of 2007 H.R. 2193, Animal Protection Accountability Improvement Act H.R. 2419, the Farm, Nutrition, and Bioenergy Act of 2007, title XI, Subtitle D, Sec. 11316 and 11317 H.R. 2419 (Senate version), Food and Energy Security Act of 2007, Title XI, Sec. 11079
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Taxation/Internal Revenue Code
Monitoring all issues related to animal welfare; Lobbied the follwing bills in entirety: H.R. 137/S.261; H.R. 503/S.311; H.R. 2964/S.1498; H.R. 661/S.394; H.R. 3029; H.R. 1280/S.714; H.R. 1726; H.R. 891; H.R. 249/H.RES.331; H.RES.427/S.RES.118; H.R. 962/S.549; H.R.2711/S.2422; H.R.2327/S.1406; H.R.2108/S.1274; H.R.2193; H.R.2491; H.R.2491; H.R.2419/S.AMDT.3776/S.AMDT.3619; S.2302/S.714
Client expense: Not reported · Firm income: Not reported
2007 · mid_year · Animals
Monitoring all issues related to animal welfare; Lobbied the follwing bills in entirety: H.R. 137/S.261; H.R. 503/S.311; H.R. 2964/S.1498; H.R. 661/S.394; H.R. 3029; H.R. 1280/S.714; H.R. 1726; H.R. 891; H.R. 249/H.RES.331; H.RES.427/S.RES.118; H.R. 962/S.549; H.R.2711/S.2422; H.R.2327/S.1406; H.R.2108/S.1274; H.R.2193; H.R.2491; H.R.2491; H.R.2419/S.AMDT.3776/S.AMDT.3619; S.2302/S.714
Client expense: Not reported · Firm income: Not reported
2007 · mid_year · Agriculture
Monitoring all issues related to animal welfare; Lobbied the follwing bills in entirety: H.R. 137/S.261; H.R. 503/S.311; H.R. 2964/S.1498; H.R. 661/S.394; H.R. 3029; H.R. 1280/S.714; H.R. 1726; H.R. 891; H.R. 249/H.RES.331; H.RES.427/S.RES.118; H.R. 962/S.549; H.R.2711/S.2422; H.R.2327/S.1406; H.R.2108/S.1274; H.R.2193; H.R.2491; H.R.2491; H.R.2419/S.AMDT.3776/S.AMDT.3619; S.2302/S.714
Client expense: Not reported · Firm income: Not reported
2007 · mid_year · Firearms/Guns/Ammunition
Monitoring all issues related to animal welfare; Lobbied the follwing bills in entirety: H.R. 137/S.261; H.R. 503/S.311; H.R. 2964/S.1498; H.R. 661/S.394; H.R. 3029; H.R. 1280/S.714; H.R. 1726; H.R. 891; H.R. 249/H.RES.331; H.RES.427/S.RES.118; H.R. 962/S.549; H.R.2711/S.2422; H.R.2327/S.1406; H.R.2108/S.1274; H.R.2193; H.R.2491; H.R.2491; H.R.2419/S.AMDT.3776/S.AMDT.3619; S.2302/S.714
Client expense: Not reported · Firm income: Not reported
2007 · mid_year · Law Enforcement/Crime/Criminal Justice
Monitoring all issues related to animal welfare; Lobbied the follwing bills in entirety: H.R. 137/S.261; H.R. 503/S.311; H.R. 2964/S.1498; H.R. 661/S.394; H.R. 3029; H.R. 1280/S.714; H.R. 1726; H.R. 891; H.R. 249/H.RES.331; H.RES.427/S.RES.118; H.R. 962/S.549; H.R.2711/S.2422; H.R.2327/S.1406; H.R.2108/S.1274; H.R.2193; H.R.2491; H.R.2491; H.R.2419/S.AMDT.3776/S.AMDT.3619; S.2302/S.714
Client expense: Not reported · Firm income: Not reported
2007 · mid_year · Trade (domestic/foreign)
Monitoring all issues related to animal welfare; Lobbied the follwing bills in entirety: H.R. 137/S.261; H.R. 503/S.311; H.R. 2964/S.1498; H.R. 661/S.394; H.R. 3029; H.R. 1280/S.714; H.R. 1726; H.R. 891; H.R. 249/H.RES.331; H.RES.427/S.RES.118; H.R. 962/S.549; H.R.2711/S.2422; H.R.2327/S.1406; H.R.2108/S.1274; H.R.2193; H.R.2491; H.R.2491; H.R.2419/S.AMDT.3776/S.AMDT.3619; S.2302/S.714
Client expense: Not reported · Firm income: Not reported
2007 · year_end · Animals
HR 1280, S 714 Pet Safety and Protection Act - To retain Class B animal dealers as a possible source for laboratory animals HR 2193 Animal Protection Accountability Act - To retain Class B animal dealers as a possible source for laboratory animals
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Animals
Animal Welfare Act Regulations & Policies Pet Safety & Protection Act - H.R. 1280 Animal Protection Accountability Improvement Act - H.R. 2193 Farm Bill Extension Act - H.R. 2419
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Animals
H.R. 137 & S. 261; The Animal Fighting Prohibition Enforcement Act: H.R. 503 & S. 311; The Horse Slaughter Protection Act S. 1498, Primates as Pets Act H.R. 661 & S. 394; to require the humane euthanasia of livestock too sick or injured to walk and prohibit USDA certification of meat from such animals for human consumption. H.R. 3029; Bear Protection Act H.R. 1280 & S. 714; to prohibit the use in research of dogs and cats obtained from random sources such as pet theft and free-to-good-home ads. H.R.1726; Farm Animal Stewardship Purchasing Act H.R.891; Fur Labeling Act H.R. 249; to restore prohibition on commercial sale and slaughter of wild horses and burros undercut by a rider in the FY 2005 omnibus spending bill. S. Res. 118 and H. Res. 427; to urge Canada to end its commercial seal hunt. H.R. 962 and S. 549; to phase out routine nontherapeutic use of antibiotics in farm animals and protect the effectiveness of antibiotics for treating sick people and animals H.R. 2711; to prohibit computer-assisted remote hunting, in which a person remotely controls the aiming and firing of a weapon to kill or injure an animal while not in the physical presence of the targeted animal. H.R. 2327 and S. 1406; to ban importation of polar bear trophies. H.R.2108 and S.1274; Human and Pet Food Safety Act H.R.2193; Animal Welfare Act Accountability Act H.R. 2491; to authorize federal provisions to provide for companion animals through uniform pet trusts after the death of the guardian/owner Formerly H.R. 2428; to stop the killing of Yellowstone bison (aka buffalo) and allow the herd to roam freely over federal lands Formerly H.R. 1688 / S. 304; to ban interstate and foreign commerce of captive exotic animals to be shot for entertainment or trophies at “canned hunts.” H.R.2419; Farm, Nutrition, and Bioenergy Act of 2007; entire bill No specific bill; no specific legislation; lobbied to codify the temporary ban that the USDA implemented processing downed cattle for the human food supply No specific bill; lobbied to amend the Humane Slaughter Act to include poultry
2007 · mid_year · Animals
H.R. 137 & S. 261; The Animal Fighting Prohibition Enforcement Act: H.R. 503 & S. 311; The Horse Slaughter Protection Act S. 1498, Primates as Pets Act H.R. 661 & S. 394; to require the humane euthanasia of livestock too sick or injured to walk and prohibit USDA certification of meat from such animals for human consumption. H.R. 3029; Bear Protection Act H.R. 1280 & S. 714; to prohibit the use in research of dogs and cats obtained from random sources such as pet theft and free-to-good-home ads. H.R.1726; Farm Animal Stewardship Purchasing Act H.R.891; Fur Labeling Act H.R. 249; to restore prohibition on commercial sale and slaughter of wild horses and burros undercut by a rider in the FY 2005 omnibus spending bill. S. Res. 118 and H. Res. 427; to urge Canada to end its commercial seal hunt. H.R. 962 and S. 549; to phase out routine nontherapeutic use of antibiotics in farm animals and protect the effectiveness of antibiotics for treating sick people and animals H.R. 2711; to prohibit computer-assisted remote hunting, in which a person remotely controls the aiming and firing of a weapon to kill or injure an animal while not in the physical presence of the targeted animal. H.R. 2327 and S. 1406; to ban importation of polar bear trophies. H.R.2108 and S.1274; Human and Pet Food Safety Act H.R.2193; Animal Welfare Act Accountability Act H.R. 2491; to authorize federal provisions to provide for companion animals through uniform pet trusts after the death of the guardian/owner Formerly H.R. 2428; to stop the killing of Yellowstone bison (aka buffalo) and allow the herd to roam freely over federal lands Formerly H.R. 1688 / S. 304; to ban interstate and foreign commerce of captive exotic animals to be shot for entertainment or trophies at “canned hunts.” No specific bill; no specific legislation; lobbied to codify the temporary ban that the USDA implemented processing downed cattle for the human food supply No specific bill; lobbied to amend the Humane Slaughter Act to include poultry
2007 · mid_year · Health Issues
HR 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007,” regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; HR 1494 / S 830, “Pediatric Medical Device Safety and Improvement Act of 2007,” regarding improving the process for the development of needed pediatric medical devices; HR 1956, “Patient Protection and Innovative Biologic Medicines Act of 2007,” regarding amending the Public Health Service Act to provide for the approval of similar biological products; HR 2193, “Animal Protection Accountability Improvement Act,” regarding amending the Animal Welfare Act to increase the penalties for violations of such Act and to prohibit the use of animals for marketing medical devices; HR 2349 / S 1413, “Uterine Fibroid Research and Education Act of 2007,” regarding providing for research and education with respect to uterine fibroids; HR 3333 / S. 1576, “Minority Health Improvement and Health Disparity Elimination Act,” regarding amending the Public Health Service Act to improve the health and healthcare of racial and ethnic minority groups; HR 788 / S 468, “Food and Drug Administration Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; HR 2900, “Food and Drug Administration Amendments Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S 1082, “Food and Drug Administration Revitalization Act,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S 1695, “Biologics Price Competition and Innovation Act of 2007,” regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products and to promote innovation in the life sciences; S 467, “Fair Access to Clinical Trials Act of 2007 or the `FACT Act',” regarding amending the Public Health Service Act to expand the clinical trials drug data bank; S 558, “Mental Health Parity Act of 2007,” regarding all provisions; S 628, “Critical Access to Health Information Technology Act of 2007,” regarding providing grants for rural health information technology development activities; S 993, “Pediatric Research Improvement Act,” regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine. HR 1165, “Swift Approval, Full Evaluation Drug Act or the `SAFE Drug Act',” regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals;
2007 · mid_year · Health Issues
development and timeline for follow-on biologics; H.R. 2193, to amend the Animal Welfare Act to increase the penalties for violations of such Act, to prohibit the use of animals for marketing medical devices, and for other purposes; S. 1505, Affordable Biologics for Consumers Act; H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007; H.R1038, To amend the Public Health Service Act to provide for the licensing of comparable and interchangeable biological products, and for other purposes; H.R.870, To amend the Public Health Service Act to provide liability protections for employees and contractors of health centers under section 330 of such Act who provide health services in emergency areas;. H.R.493/S.358, Genetic Information Nondiscrimination Act of 2007. H.R.2900, Food and Drug Administration Amendments Act of 2007, provisions relating to user fees, reimportation, anti-counterfieting and follow-on biologics; S.1082, Prescription Drug User Fee Amendments of 2007, provisions relating to user fees and pedigree issues, vaccines and countermeasures policies; H.R. 2424/S.1376, 340B Program Improvement and Integrity Act of 2007, provisions related to drug pricing; S.1695, Biologics Price Competition and Innovation Act of 2007, provisions relating to
Client expense: $1,120,000 · Firm income: Not reported
2007 · mid_year · Animals
Animal Welfare Act regulations and legislation Pet Safety & Protection Act - H.R. 1280 Animal Protection Accountability Improvement Act - H.R. 2193
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2007 · mid_year · Animals
Animal Welfare Act Regulations & Policies Pet Safety & Protection Act - H.R. 1280 Animal Protection Accountability Improvement Act - H.R. 2193 Farm Bill Extension Act - H.R. 2419
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| PA |
| Mark Kirk | Republican | IL |
| Robert Wexler | Democratic | FL |
| Steve Cohen | Democratic | TN |
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $1,500,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $1,700,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $40,000
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $3,820,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)